The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial

James C. Johnston, Mia L. van der Kop, Kirsten Smillie, Gina Ogilvie, Fawziah Marra, Mohsen Sadatsafavi, Kamila Romanowski, Matthew A. Budd, Jan Hajek, Victoria Cook, Richard T. Lester

Source: Eur Respir J, 51 (2) 1701488; 10.1183/13993003.01488-2017
Journal Issue: February
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
James C. Johnston, Mia L. van der Kop, Kirsten Smillie, Gina Ogilvie, Fawziah Marra, Mohsen Sadatsafavi, Kamila Romanowski, Matthew A. Budd, Jan Hajek, Victoria Cook, Richard T. Lester. The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial. Eur Respir J, 51 (2) 1701488; 10.1183/13993003.01488-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova
Source: Eur Respir J, 56 (2) 2000493; 10.1183/13993003.00493-2020
Year: 2020



A self-management programme for COPD: a randomised controlled trial
Source: Eur Respir J 2014; 44: 1538-1547
Year: 2014



No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial
Source: ERJ Open Res, 6 (4) 00342-2020; 10.1183/23120541.00342-2020
Year: 2020



Effectiveness of an individualized action plan on health status recovery in patients with COPD: A randomized controlled trial
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010


Compliance with short and long pulmonary rehabilitation programmes: a randomised controlled trial
Source: Annual Congress 2003 - Outcome of pulmonary rehabilitation
Year: 2003


Helium-hyperoxia a novel treatment for optimizing pulmonary rehabilitation: a randomized controlled trial
Source: Eur Respir J 2007; 30: Suppl. 51, 327s
Year: 2007

Clinical effect on asthma control using a novel digital self-management solution: a physician blinded randomized controlled crossover trial
Source: International Congress 2019 – Medical education to improve practice
Year: 2019




Late-breaking abstract: The effects of roxithromycin as anti-inflammatoy agent on clinical outcomes in patient with bronchiectasis: A double blinded randomized controlled study
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Year: 2011



Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Source: Eur Respir J 2001; 17: 206-213
Year: 2001



Experimental hookworm infection as potential therapy for asthma: a randomised placebo controlled trial
Source: Annual Congress 2009 - Epidemiology of atopy and asthma
Year: 2009

Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial
Source: Eur Respir J, 54 (5) 1900983; 10.1183/13993003.00983-2019
Year: 2019



Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial
Source: Eur Respir J, 58 (6) 2004388; 10.1183/13993003.04388-2020
Year: 2021



Effectiveness of a pharmacist intervention for asthma control improvement: randomised controlled trial
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007


Efficacy of an integrated internet community program after pulmonary rehabilitation for COPD patients: a pilot randomized control trial
Source: International Congress 2017 – The importance of physical activity in patients with COPD
Year: 2017




Vitamin D as a supplementary agent in the treatment of pulmonary tuberculosis: A systematic review and meta-analysis of randomized controlled trials
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013

Late Breaking Abstract - Effect on asthma control using a novel digital self-management system: a physician blinded randomised controlled cross-over pilot trial
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018


A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?
Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018
Year: 2018



RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study
Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases
Year: 2021



Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017